UPDATE: Mizuho Securities Downgrades Corvus Pharmaceuticals (CRVS) to Neutral
Tweet Send to a Friend
(Updated - February 10, 2021 4:56 AM EST)
Mizuho Securities analyst Mara Goldstein downgraded Corvus Pharmaceuticals (NASDAQ: CRVS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Mizuho Securities analyst Mara Goldstein downgraded Corvus Pharmaceuticals (NASDAQ: CRVS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
